Epinephrine ophthalmic Interactions
There are 52 drugs known to interact with epinephrine ophthalmic, along with 5 disease interactions. Of the total drug interactions, 5 are major, and 47 are moderate.
- View all 52 medications that may interact with epinephrine ophthalmic
- View epinephrine ophthalmic disease interactions (5)
Most frequently checked interactions
View interaction reports for epinephrine ophthalmic and the medicines listed below.
- Adalat XL Plus (aspirin / nifedipine)
- Alaway (ketotifen ophthalmic)
- Aldomet (methyldopa)
- Amitiza (lubiprostone)
- Anusol-HC (hydrocortisone topical)
- Anusol-HC Suppositories (hydrocortisone topical)
- Aspir 81 (aspirin)
- Benadryl (diphenhydramine)
- Botox (onabotulinumtoxinA)
- BuSpar (buspirone)
- Claritin (loratadine)
- Crestor (rosuvastatin)
- Dexamethasone Intensol (dexamethasone)
- Dulera (formoterol / mometasone)
- Estarylla (ethinyl estradiol / norgestimate)
- Estrace (estradiol)
- Euthyrox (levothyroxine)
- Fasenra (benralizumab)
- Jolivette (norethindrone)
- Lantus (insulin glargine)
- Lidoderm (lidocaine topical)
- Maxolon (metoclopramide)
- Mirena (levonorgestrel)
- Morphine Sulfate ER (morphine)
- NovoLog FlexPen (insulin aspart)
- Nurtec ODT (rimegepant)
- Odactra (house dust mite allergen extract)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
Epinephrine ophthalmic disease interactions
There are 5 disease interactions with epinephrine ophthalmic which include:
More about epinephrine ophthalmic
- epinephrine ophthalmic consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.